Basal cell carcinoma. Basal cell carcinoma of skin of lip
Conditions
Interventions
Intervention group: 1-2 ml of the 50mg/ml 5FU solution (Kavosh Gostar Darou, Iran) will be injected in to the BCC lesion once a week until the resolution of the lesion or for a maximum duration of 6 w
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: People with BCC who are willing to participate in the study People with BCC who can go to the clinic for visiting
Exclusion criteria
Exclusion criteria: Recurrent BCC Very large BCC (larger than 2 cm) BCC around the eyes Patients with lymphoma or leukemia or immunodeficiency or in pregnant or lactating patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment the complete improvement or shrinkage of the lesion. Timepoint: Weekly until the healing of lesion or up to 6 weeks. Method of measurement: Observation and questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of response to treatment based on initial size, anatomical location, pathology type, and duration of lesion formation and investigation the response to treatment based on age and gender. Timepoint: Weekly until the healing of lesion or up to 6 weeks. Method of measurement: Observation and questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKhetere Zahedi
Shahid Beheshti University of Medical Sciences
Outcome results
None listed